Kathy Lee Seung Min, Yoon Kang Hyun, Park Jimin, Kim Hyun Soo, Woo Jong Shin, Lee So Ra, Lee Kyung Hye, Jang Hyun-Hee, Kim Jin-Bae, Kim Woo Shik, Lee Sanghoon, Kim Weon
Department of Acupuncture and Moxibustion, College of Korean Medicine, Kyung Hee University, Seoul 02453, Republic of Korea.
Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University, Seoul 02447, Republic of Korea.
Evid Based Complement Alternat Med. 2015;2015:625645. doi: 10.1155/2015/625645. Epub 2016 Jan 11.
Many preclinical studies show that electroacupuncture (EA) on PC6 and ST36 can reduce infarct size after ischemia-reperfusion (IR) injury. Yet studies to enhance the treatment effect size are limited. The purpose of this study was to explore whether EA has additional myocardial protective effects on an ischemia-reperfusion (IR) injury rat model when back-shu EA and moxibustion are added. SD rats were divided into several groups and treated with either EA only, EA + back-shu EA (B), or EA + B + moxibustion (M) for 5 consecutive days. Transthoracic echocardiography and molecular and immunohistochemical evaluations were performed. It was found that although myocardial infarct areas were significantly lower and cardiac function was also significantly preserved in the three treatment groups compared to the placebo group, there were no additional differences between the three treatment groups. In addition, HSP20 and HSP27 were expressed significantly more in the treatment groups. The results suggest that adding several treatments does not necessarily increase protection. Our study corroborates previous findings that more treatment, such as prolonging EA duration or increasing EA intensity, does not always lead to better results. Other methods of increasing treatment effect size should be explored.
许多临床前研究表明,针刺内关穴(PC6)和足三里穴(ST36)可减小缺血再灌注(IR)损伤后的梗死面积。然而,旨在增强治疗效果大小的研究有限。本研究的目的是探讨在缺血再灌注(IR)损伤大鼠模型中,当增加背俞穴针刺和艾灸时,针刺是否具有额外的心肌保护作用。将SD大鼠分为几组,分别连续5天仅接受针刺治疗、针刺 + 背俞穴针刺(B组)或针刺 + B组 + 艾灸(M组)治疗。进行经胸超声心动图检查以及分子和免疫组织化学评估。结果发现,与安慰剂组相比,三个治疗组的心肌梗死面积均显著降低,心脏功能也得到显著保留,但三个治疗组之间没有额外差异。此外,热休克蛋白20(HSP20)和热休克蛋白27(HSP27)在治疗组中的表达明显更高。结果表明,增加多种治疗方法不一定能增强保护作用。我们的研究证实了先前的发现,即更多的治疗,如延长针刺持续时间或增加针刺强度,并不总是能带来更好的结果。应探索其他增加治疗效果大小的方法。